Combination therapy with a glucagon receptor (GCGR) antibody and an anti-CD3 antibody Grant US-11845802-B2 United States of America 19 Dec 2023
Methods of reducing or lowering blood glucose levels in a human subject by administering… Grant US-11732049-B2 United States of America 22 Aug 2023
PEPTIDES AND FRAGMENTS FOR TREATING DIABETES AND ASSOCIATED METABOLIC DISEASES Application WO-2023062545-A1 World Intellectual Property Organisation (WIPO) 20 Apr 2023
METHOD AND COMPOUNDS FOR TREATING DIABETES AND ASSOCIATED METABOLIC DISEASES Application WO-2022079612-A1 World Intellectual Property Organisation (WIPO) 21 Apr 2022
Antibodies which bind human glucagon receptor Grant US-10995145-B2 United States of America 04 May 2021
Method of treating type I diabetes by administering a combination of a glucagon receptor… Grant US-10961315-B2 United States of America 30 Mar 2021
COMPOSITIONS FOR AND METHODS OF DIAGNOSING, PROGNOSING, AND TREATING DIABETES Application US-20210018520-A1 United States of America 21 Jan 2021
PEPTIDES AND METHODS FOR TREATING DISEASES Application WO-2021011437-A1 World Intellectual Property Organisation (WIPO) 21 Jan 2021
ANTI-CD40 ANTIBODIES FOR USE IN TREATMENT OF T1DM AND INSULITIS Application WO-2020225736-A1 World Intellectual Property Organisation (WIPO) 12 Nov 2020
METHODS OF TREATING DIABETES USING DEVICES FOR CELLULAR TRANSPLANTATION Application WO-2020223670-A1 World Intellectual Property Organisation (WIPO) 05 Nov 2020